BRCA2 and ovarian cancer: Since the majority of both BRCA1 and BRCA2 ovarian cancer associated cancer tumors are high-grade serous ([19] and S2 Table) to increase the power of the association analyses, a meta-analysis combining HRs for the association of variants with ovarian cancer risk in BRCA1 and BRCA2 was conducted.